Total number of patients
| 69 | 46 | 14 | 9 |
Male/female
| 40/29 | 29/17 | 7/7 | 4/5 |
Age (months) at ICP monitoring
|
Median (range) | 66 (12 to 358) | 65 (12 to 358) | 93 (20 to 255) | 46 (21 to 234) |
Clinical symptoms before ICP monitoring
|
Headache | 41 (59) | 26 (57) | 9 (64) | 6 (67) |
Irritability | 29 (42) | 21 (46) | 4 (29) | 4 (44) |
Nausea | 19 (28) | 10 (22) | 3 (21) | 6 (67) |
Lethargy | 24 (35) | 18 (39) | 3 (21) | 3 (33) |
Epileptic seizures | 9 (13) | 5 (11) | 3 (21) | 1 (11) |
Positional symptoms
|
Relief by lying down | 15 (22) | 7 (15) | 7 (50) | 1 (11) |
Relief by sitting up | 7 (10) | 5 (11) | 2 (14) | |
Worsening by lying down | 5 (7) | 3 (7) | 2 (14) | |
Worsening by sitting up | 5 (7) | 1 (2) | 4 (29) | |
Day and night variation in symptoms
|
Worst in the morning | 5 (7) | 3 (7) | | 2 (22) |
Worst in the evening | 5 (7) | 2 (4) | 2 (14) | 1 (11) |
Worst in the night | 6 (9) | 5 (11) | | 1 (11) |
Clinical indications for ICP monitoring
|
Clinically suspected increased ICP | 45 (65) | 33 (72) | 4 (29) | 8 (89) |
Clinically suspected reduced ICP | 24 (35) | 13 (28) | 10 (71) | 1 (11) |
Mean ICP during sleep
|
<10.0 mm Hg | 37 (54) | 24 (52) | 13 (93) | |
10.0 to 15.0 mm Hg | 28 (41) | 22 (48) | 1 (7) | 5 (56) |
>15.0 mm Hg | 4 (6) | | | 4 (44) |
Mean ICP during the awake state
|
<10.0 mm Hg | 56 (81) | 41 (89) | 13 (93) | 2 (22) |
10.0 to 15.0 mm Hg | 8 (12) | 5 (11) | 1 (7) | 2 (22) |
>15.0 mm Hg | 5 (7) | | | 5 (56) |
Outcome after management
|
Relief of symptoms | 29 (42) | 16 (35) | 6 (43) | 7 (78) |
Lasting and unchanged symptoms | 40 (58) | 30 (65) | 8 (57) | 2 (22) |